Metraipolis › archive › dc_47f92d63d8a7
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma — Europe PMC PMID:41127009
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41127009
- DOI
- 10.3389/fonc.2025.1669526
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T12:33:05.738Z
- SHA-256 of the archived text
24e3e9c4174ad0729ccda2ae4503c6beecd3d2c9400d6390f69115ee33a1d545- Stable URL of this page
https://metraipolis.com/documento/dc_47f92d63d8a7
How to cite
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma — Europe PMC PMID:41127009 — Europe PMC (en), https://europepmc.org/article/MED/41127009 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_47f92d63d8a7 (Metraipolis archive dc_47f92d63d8a7, sha256 24e3e9c4174ad0729ccda2ae4503c6beecd3d2c9400d6390f69115ee33a1d545)
BibTeX
@misc{dc47f92d63d8a7,
title = {Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma — Europe PMC PMID:41127009},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41127009},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_47f92d63d8a7; sha256 24e3e9c4174ad0729ccda2ae4503c6beecd3d2c9400d6390f69115ee33a1d545},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41127009. Agents can read the archived copy with the MCP tool read_document.